Table 2.
In drug development | In Phase II trials | Tried and failed |
---|---|---|
| ||
atomoxetine, N-acetylcysteine, tiagabine, vigabatrin | baclofen, carvedilol, d-cycloserine, labetalol, lorcanserin, topiramate | buspirone, EVT 302, GSK598809, lobeline, mecamylamine, menthyl valerate/eucalyptus oil/camphor/quinine (nicobrevin), naltrexone, reboxetine, rimonabant, selegiline silver acetate, surinabant, vaccines |